These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33493768)

  • 1. Elastin-like hydrogel stimulates angiogenesis in a severe model of critical limb ischemia (CLI): An insight into the glyco-host response.
    Marsico G; Jin C; Abbah SA; Brauchle EM; Thomas D; Rebelo AL; Orbanić D; Chantepie S; Contessotto P; Papy-Garcia D; Rodriguez-Cabello C; Kilcoyne M; Schenke-Layland K; Karlsson NG; McCullagh KJA; Pandit A
    Biomaterials; 2021 Feb; 269():120641. PubMed ID: 33493768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
    Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
    Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An injectable elastin-based gene delivery platform for dose-dependent modulation of angiogenesis and inflammation for critical limb ischemia.
    Dash BC; Thomas D; Monaghan M; Carroll O; Chen X; Woodhouse K; O'Brien T; Pandit A
    Biomaterials; 2015 Oct; 65():126-39. PubMed ID: 26151745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis
    Ibáñez-Fonseca A; Rico A; Preciado S; González-Pérez F; Muntión S; García-Briñón J; García-Macías MC; Rodríguez-Cabello JC; Pericacho M; Alonso M; Sánchez-Guijo F
    Front Bioeng Biotechnol; 2022; 10():918602. PubMed ID: 35814011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of angiogenesis and host response by modulating the cell adhesion properties of an Elastin-Like Recombinamer-based hydrogel.
    Staubli SM; Cerino G; Gonzalez De Torre I; Alonso M; Oertli D; Eckstein F; Glatz K; Rodríguez Cabello JC; Marsano A
    Biomaterials; 2017 Aug; 135():30-41. PubMed ID: 28482232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel model of chronic limb ischemia to therapeutically evaluate the angiogenic effects of drug candidates.
    Shimatani K; Sato H; Saito A; Sasai M; Watanabe K; Mizukami K; Kamohara M; Miyagawa S; Sawa Y
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1124-H1135. PubMed ID: 33481698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sourcing of human peripheral blood-derived myeloid angiogenic cells under xeno-free conditions for the treatment of critical limb ischemia.
    Wong CWT; Sawhney A; Wu Y; Mak YW; Tian XY; Chan HF; Blocki A
    Stem Cell Res Ther; 2022 Aug; 13(1):419. PubMed ID: 35964057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible Thermoresponsive Hydrogel Fabricated from Natural Biopolymer for the Improvement of Critical Limb Ischemia by Controlling Release of Stem Cells.
    Wang R; Yao X; Li T; Li X; Jin M; Ni Y; Yuan W; Xie X; Lu L; Li M
    Adv Healthc Mater; 2019 Oct; 8(20):e1900967. PubMed ID: 31557404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic angiogenesis using zinc oxide nanoflowers for the treatment of hind limb ischemia in a rat model.
    Barui AK; Nethi SK; Basuthakur P; Jhelum P; Bollu VS; Reddy BR; Chakravarty S; Patra CR
    Biomed Mater; 2021 Mar; 16(4):. PubMed ID: 33657534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelatin-based micro-hydrogel carrying genetically engineered human endothelial cells for neovascularization.
    Choi YH; Kim SH; Kim IS; Kim K; Kwon SK; Hwang NS
    Acta Biomater; 2019 Sep; 95():285-296. PubMed ID: 30710712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia.
    Beltran-Camacho L; Jimenez-Palomares M; Rojas-Torres M; Sanchez-Gomar I; Rosal-Vela A; Eslava-Alcon S; Perez-Segura MC; Serrano A; Antequera-González B; Alonso-Piñero JA; González-Rovira A; Extremera-García MJ; Rodriguez-Piñero M; Moreno-Luna R; Larsen MR; Durán-Ruiz MC
    Stem Cell Res Ther; 2020 Mar; 11(1):106. PubMed ID: 32143690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient mice.
    Bréchot N; Gomez E; Bignon M; Khallou-Laschet J; Dussiot M; Cazes A; Alanio-Bréchot C; Durand M; Philippe J; Silvestre JS; Van Rooijen N; Corvol P; Nicoletti A; Chazaud B; Germain S
    PLoS One; 2008; 3(12):e3950. PubMed ID: 19079608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy.
    Nammian P; Asadi-Yousefabad SL; Daneshi S; Sheikhha MH; Tabei SMB; Razban V
    Stem Cell Res Ther; 2021 Jan; 12(1):58. PubMed ID: 33436054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of basic fibroblast growth factor from acoustically-responsive scaffolds promotes therapeutic angiogenesis in the hind limb ischemia model.
    Jin H; Quesada C; Aliabouzar M; Kripfgans OD; Franceschi RT; Liu J; Putnam AJ; Fabiilli ML
    J Control Release; 2021 Oct; 338():773-783. PubMed ID: 34530052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tethering QK peptide to enhance angiogenesis in elastin-like recombinamer (ELR) hydrogels.
    Flora T; de Torre IG; Alonso M; Rodríguez-Cabello JC
    J Mater Sci Mater Med; 2019 Feb; 30(2):30. PubMed ID: 30762134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia.
    Zhao N; Yue Z; Cui J; Yao Y; Song X; Cui B; Qi X; Han Z; Han ZC; Guo Z; He ZX; Li Z
    Stem Cell Res Ther; 2019 Apr; 10(1):129. PubMed ID: 31036073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite Hydrogel Modified by IGF-1C Domain Improves Stem Cell Therapy for Limb Ischemia.
    Wang X; Zhang J; Cui W; Fang Y; Li L; Ji S; Mao D; Ke T; Yao X; Ding D; Feng G; Kong D
    ACS Appl Mater Interfaces; 2018 Feb; 10(5):4481-4493. PubMed ID: 29327586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization.
    Robinson ST; Douglas AM; Chadid T; Kuo K; Rajabalan A; Li H; Copland IB; Barker TH; Galipeau J; Brewster LP
    Acta Biomater; 2016 May; 36():86-98. PubMed ID: 26961805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls.
    Gremmels H; Teraa M; Quax PH; den Ouden K; Fledderus JO; Verhaar MC
    Mol Ther; 2014 Nov; 22(11):1960-70. PubMed ID: 25174586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogel-based therapeutic angiogenesis: An alternative treatment strategy for critical limb ischemia.
    Xing Z; Zhao C; Wu S; Zhang C; Liu H; Fan Y
    Biomaterials; 2021 Jul; 274():120872. PubMed ID: 33991951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.